People · Operator

Daniel Ward

Named in public records as an officer, director or promoter · active 2021–2025 · Other Technology, Other

3
Companies
7
Filings
$64.8M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Orderful Inc.Other TechnologySeries B$35.5M$24.4M2021
Pipe17, Inc.OtherSeries B$28.1M$104.4M2025
Revaly, Inc.Other TechnologyPre-Seed$1.1M$756K2023
Operator network

Daniel Ward at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David Ulevitch · 11 companies · 1 sharedDavid UlevitchJohn McCarthy · 6 companies · 1 sharedJohn McCarthyErik Kiser · 1 companies · 1 sharedErik KiserGregoire Lehmann · 1 companies · 1 sharedGregoire LehmannJohn Seung · 5 companies · 1 sharedJohn SeungJohn Zagula · 5 companies · 1 sharedJohn ZagulaAlan Yang · 3 companies · 1 sharedAlan YangMo Afshar · 1 companies · 1 sharedMo AfsharMohamad Afshar · 1 companies · 1 sharedMohamad AfsharDavid Dunn · 2 companies · 1 sharedDavid DunnGraham Bredemeyer · 2 companies · 1 sharedGraham BredemeyerDavid W. Dunn · 1 companies · 1 sharedDavid W. DunnPaul W. Anuszkiewicz · 1 companies · 1 sharedPaul W. Anuszkiew…Orderful Inc. · $35.5M raisedOrderful Inc.Pipe17, Inc. · $28.1M raisedPipe17, Inc.Revaly, Inc. · $1.1M raisedRevaly, Inc.Daniel WardDW
Daniel Ward Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Daniel Ward on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David Ulevitch111
John McCarthy16
John Seung15
John Zagula15
Alan Yang13
Graham Bredemeyer12
David Dunn12
Mo Afshar11
Erik Kiser11
David W. Dunn11
Paul W. Anuszkiewicz11
Gregoire Lehmann11
Mohamad Afshar11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.